Stock Taper Revenue: Approximately $33,000 for Q2 2026, up from $26,000 in Q2 2025.
Net Loss: $6.6 million, or $0.04 per share, compared to a net loss of $5 million, or $0.04 per share, in the same quarter last year.
Deferred Revenue: Approximately $100,000 as of June 30, 2026, pending milestone achievements under a joint development agreement.
Cash Position: $95.9 million in cash, cash equivalents, and marketable securities, providing significant financial flexibility.
Operating Expenses: Increased R&D expenses to $3.9 million (up from $2.6 million) and G&A expenses to $3.4 million (up from $2.3 million) reflecting investments in technology and infrastructure.
Transitioning from technology development to commercialization with 5 Stage 3 customers.
Progress in silicon photonics foundry engagements, with wafers expected to be delivered in August.
Strong demand for optical networking solutions, particularly in AI infrastructure, with significant growth reported by industry peers.
Active foundry ecosystem includes GlobalFoundries, Tower Semiconductor, SilTerra, and a fourth unnamed partner.
New material supply and licensing agreements are being negotiated, with one already in place.
Anticipation of busy fourth quarter with customer-facing technical activities and engineering work.
Focus on moving Stage 3 programs towards qualification and Stage 4, with expectations for increased commercial agreements.
Plans for production ramp beginning in 2027, supported by ongoing investments in manufacturing capabilities and infrastructure.
Continued pressure on foundries regarding capacity, process development, and yield learning, which could impact timelines.
The transition from prototype runs to qualification is complex and may face delays due to various factors including design changes and testing.
The competitive landscape remains intense, with various materials and solutions being explored by industry players, raising concerns about market positioning.
Foundry ecosystem bottlenecks include capacity, process development, and integration challenges, particularly in back-end production.
The current cash balance is deemed sufficient to support the company’s growth strategy without major changes to the development timeline.
Licensing agreements will vary in dollar terms based on material pricing and customer success in the market.
The company is cautious about claiming exclusivity of their Perkinamine material, acknowledging competition and the need for continued demonstration of its value.
The pipeline of customers in earlier stages remains strong, with ongoing wafer runs expected to boost confidence and facilitate movement to Stage 3. This summary encapsulates the key points from the earnings call, providing a clear overview of Lightwave Logic's financial performance, strategic direction, and the challenges it faces moving forward.
SOURCE: Q2 2026 EARNINGS CALL TRANSCRIPT